Uncategorized
AI Is Rewriting Drug Discovery
The $2.5 billion market for AI-driven drug discovery is forcing pharmaceutical companies and universities to abandon their old playbooks entirely.
Molekula Blog
Uncategorized
The Chemistry Search Crisis: Why $4.5B in Tools Can't Keep Pace with Science
Chemists spend half their time searching outdated databases. Here's why the industry's dominant tools are failing researchers—and what needs to change.
Professor Spotlight: Richmond Sarpong
When Richmond Sarpong was a kid in Ghana, he watched his father distribute ivermectin to treat river blindness. Seeing that drug work changed his life. Today at UC Berkeley, Sarpong synthesizes complex molecules and figures out how computers can help chemists do it faster.
Blog
I Spent a Decade Watching Chemists Waste Half Their Time Searching
From Roche to building Molekula.ai, an AI synthesis assistant that understands molecular structures instead of keywords.